Britannia Life Sciences, Inc.

  • Market Cap: Micro Cap
  • Industry: Other Agricultural Products
  • ISIN: CA11042D1087
CAD
0.08
-0.01 (-11.11%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
0.38
0.21
0.17
0.17
0.23
1.77
1.73
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
0.38
0.21
0.17
0.17
0.23
1.77
1.73
Raw Material Cost
0.05
0.09
0.16
0.12
0.09
0.65
1.16
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.11
0.52
0.32
0.51
0.20
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.01
0.01
0.10
0.01
0.28
0.35
Selling and Distribution Expenses
0.40
0.72
0.38
0.67
0.35
0.95
0.24
Other Expenses
-0.01
-0.05
-0.03
-0.06
-0.02
-0.03
-0.03
Total Expenditure (Excl Depreciation)
0.45
0.81
0.53
0.79
0.44
1.60
1.40
Operating Profit (PBDIT) excl Other Income
-0.1
-0.6
-0.4
-0.6
-0.2
0.2
0.3
Other Income
14.01
0.14
1.45
0.59
-0.92
-0.04
0.03
Operating Profit (PBDIT)
13.96
-0.44
1.10
-0.01
-1.11
0.19
-4.79
Interest
0.01
0.01
0.01
0.10
0.01
0.28
0.35
Exceptional Items
-1.41
0.06
0.13
0.00
0.00
0.00
0.06
Gross Profit (PBDT)
0.33
0.12
0.01
0.05
0.14
1.12
0.57
Depreciation
0.02
0.02
0.02
0.02
0.02
0.08
0.12
Profit Before Tax
12.53
-0.41
1.21
-0.13
-1.14
-0.16
-5.20
Tax
1.67
0.00
0.00
0.00
0.00
-0.01
-0.40
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
10.84
-0.41
-0.69
-0.35
-1.54
-0.74
-5.91
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
10.84
-0.41
-0.69
-0.35
-1.54
-0.74
-5.91
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.04
0.11
0.07
0.34
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
10.84
-0.41
-0.69
-0.30
-1.43
-0.67
-5.57
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
17.23
5.05
5.55
1.18
1.52
1.91
2.44
Earnings per share (EPS)
0.07
-0.0
-0.0
-0.0
-0.01
-0.0
-0.04
Diluted Earnings per share
0.07
-0.0
-0.0
-0.0
-0.01
-0.0
-0.04
Operating Profit Margin (Excl OI)
-18.07%
-283.41%
-213.44%
-369.06%
-87.63%
9.28%
-285.7%
Gross Profit Margin
3326.8%
-186.6%
723.39%
-67.72%
-477.96%
-4.82%
-293.28%
PAT Margin
2874.76%
-194.75%
-406.99%
-205.5%
-658.03%
-41.8%
-341.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 100.00% vs -88.89% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 3,700.00% vs -200.00% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 83.33% vs -700.00% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is -100.00% vs -66.67% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of Britannia Life Sciences, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CAD)
Change(%)
Net Sales
0.38
0.01
0.37
3,700.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
0.38
0.01
0.37
3,700.00%
Raw Material Cost
0.05
0.01
0.04
400.00%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.11
0.00
0.11
Power Cost
0
0
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.40
0.44
-0.04
-9.09%
Other Expenses
-0.01
0.00
-0.01
Total Expenditure (Excl Depreciation)
0.45
0.48
-0.03
-6.25%
Operating Profit (PBDIT) excl Other Income
-0.07
-0.47
0.40
85.11%
Other Income
14.01
-0.07
14.08
20,114.29%
Operating Profit (PBDIT)
13.96
-0.53
14.49
2,733.96%
Interest
0.01
0.00
0.01
Exceptional Items
-1.41
-0.30
-1.11
-370.00%
Gross Profit (PBDT)
0.33
0.00
0.33
Depreciation
0.02
0.01
0.01
100.00%
Profit Before Tax
12.53
-0.85
13.38
1,574.12%
Tax
1.67
0.00
1.67
Provisions and contingencies
0
0
0.00
Profit After Tax
10.84
-0.85
11.69
1,375.29%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
10.84
-0.85
11.69
1,375.29%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
10.84
-0.85
11.69
1,375.29%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
17.23
0.46
16.77
3,645.65%
Earnings per share (EPS)
0.07
-0.00
0.07
Diluted Earnings per share
0.07
-0.00
0.07
Operating Profit Margin (Excl OI)
-18.07%
-3,592.31%
0.00
3,574.24%
Gross Profit Margin
3,326.80%
-6,415.38%
0.00
9,742.18%
PAT Margin
2,874.76%
-6,515.38%
0.00
9,390.14%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 0.04 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 100.00% vs 0.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 100.00% vs -88.89% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.08 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 2,800.00% vs 42.86% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 3,700.00% vs -200.00% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.01 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 83.33% vs -100.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 83.33% vs -700.00% in Dec 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -18.07%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024